Thrombopoietin mimetics are drugs that considerably increase platelet production by stimulating the receptor for the hormone thrombopoietin; Romiplostim and Eltrombopag are examples.[1] Thrombopoietin mimetics are a type of thrombopoietic agents. There has been a development of a registry of pregnant patients that were treated with these drugs.[2]
References
edit- ^ "JPAC - Transfusion Guidelines".
- ^ Ronald Hoffman; Edward J. Benz, Jr.; Leslie E. Silberstein; Helen Heslop; Jeffrey Weitz; John Anastasi (2013). Hematology: Basic Principles and Practice. Elsevier Health Sciences. p. 2135.